Order Article Reprints

Watabe K, Kan M, Ohno I, Uchida S, Sudo T, Yokozuka K, Abe A, Nakaya Y, Ogane Y, Kurosaki H, et al. Prognostic Impact of Unplanned Hospitalization During First-Line Gemcitabine Plus Nab-Paclitaxel Therapy for Unresectable Pancreatic Cancer: A Single-Center Retrospective Observational Study. Cancers. 2026; 18(2):194. https://doi.org/10.3390/cancers18020194

Watabe, Kazuki, Motoyasu Kan, Izumi Ohno, Sodai Uchida, Taiga Sudo, Koki Yokozuka, Akinori Abe, Yoshiki Nakaya, Yoshiki Ogane, Hiroki Kurosaki, and et al. 2026. "Prognostic Impact of Unplanned Hospitalization During First-Line Gemcitabine Plus Nab-Paclitaxel Therapy for Unresectable Pancreatic Cancer: A Single-Center Retrospective Observational Study" Cancers 18, no. 2: 194. https://doi.org/10.3390/cancers18020194

Watabe, K., Kan, M., Ohno, I., Uchida, S., Sudo, T., Yokozuka, K., Abe, A., Nakaya, Y., Ogane, Y., Kurosaki, H., Sakai, M., Sekine, Y., Takahashi, T., Ouchi, M., Ohyama, H., Sakai, N., Takano, S., Takayashiki, T., Ohtsuka, M., & Kato, J. (2026). Prognostic Impact of Unplanned Hospitalization During First-Line Gemcitabine Plus Nab-Paclitaxel Therapy for Unresectable Pancreatic Cancer: A Single-Center Retrospective Observational Study. Cancers, 18(2), 194. https://doi.org/10.3390/cancers18020194